Eureka! Institutional Repository

Introduction: Cortisone which is administered in patients with interstitial lung disease as treatment, increases blood glucose values and can lead to occurrence of diabetes mellitus. Purpose: the purpose of the study was to determine the importance of cortisone’s administration, for the appearance of diabetes, to a specific group of patients with interstitial lung disease. Methodology: this is a retrospective study, the population of which included 150 patients who had been examined in the outpatient clinic of Interstitial lung diseases of the Public General Hospital of Thessaloniki “G. Papanikolaou”. Of these, 86 patients were female (57.3%) and 64 were men (42.7%). Twenty one (21) (14%) of the patients had diabetes, while 129 did not experience it. For data collection, the following tools were used: a) Patients' records from the hospital infirmary and b) telephone communication with patients. Statistical analysis was performed with the SPSS statistical program 20. Results: in 14% of patients of the sample in total, appeared diabetes mellitus, after > 2 years of the initial disease and of the administration of cortizone. Of them, 10 patients were men and 11 women. Powerful Statistical association was found between heredity and the appearance of Diabetes Mellitus (P =0,000) in patients with interstitial lung disease. Conclusions: Patients with interstitial lung disease, who are taking cortisone in their therapeutic treatment, if they have also heredity of diabetes mellitus, it’s possible for them to develop the disease. The time of administration of cortisone and sex are factors that don’t contribute to its appearance.